Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 199.75%366M | ---- | -49.86%122.1M | ---- | -73.55%243.5M | ---- | 16,337.50%920.5M | ---- | 102.87%5.6M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 8.64%-22.2M | ---- | -62.00%-24.3M | ---- | -177.78%-15M | ---- | -184.21%-5.4M | ---- | 83.04%-1.9M |
| Impairment and provisions: | ---- | --53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | --53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 241.67%1.7M | ---- | -500.00%-1.2M | ---- | 400.00%300K | ---- | -107.14%-100K | ---- | 366.67%1.4M |
| -Other fair value changes | ---- | 241.67%1.7M | ---- | -500.00%-1.2M | ---- | 400.00%300K | ---- | -107.14%-100K | ---- | 366.67%1.4M |
| Asset sale loss (gain): | ---- | 480.77%15.1M | ---- | -71.11%2.6M | ---- | 291.30%9M | ---- | 15.00%2.3M | ---- | 233.33%2M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 480.77%15.1M | ---- | -71.11%2.6M | ---- | 291.30%9M | ---- | 15.00%2.3M | ---- | 233.33%2M |
| Depreciation and amortization: | ---- | 8.12%1.01B | ---- | 17.73%930.2M | ---- | -12.02%790.1M | ---- | -3.21%898M | ---- | -4.31%927.8M |
| -Depreciation | ---- | 8.12%1.01B | ---- | 17.73%930.2M | ---- | -12.02%790.1M | ---- | -3.21%898M | ---- | -4.31%927.8M |
| Financial expense | ---- | 6.66%390.8M | ---- | 18.46%366.4M | ---- | -5.99%309.3M | ---- | -18.04%329M | ---- | -23.27%401.4M |
| Special items | ---- | 6.52%-4.3M | ---- | 57.01%-4.6M | ---- | -314.00%-10.7M | ---- | -75.73%5M | ---- | --20.6M |
| Operating profit before the change of operating capital | ---- | 29.80%1.81B | ---- | 4.88%1.39B | ---- | -38.28%1.33B | ---- | 58.40%2.15B | ---- | -5.58%1.36B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -139.10%-191.7M | ---- | 257.20%490.3M | ---- | -63.90%-311.9M | ---- | -1,112.10%-190.3M | ---- | 92.47%-15.7M |
| Accounts receivable (increase)decrease | ---- | -32.25%-166.9M | ---- | 11.56%-126.2M | ---- | -35,775.00%-142.7M | ---- | -99.77%400K | ---- | 154.94%170.3M |
| Accounts payable increase (decrease) | ---- | -168.15%-45.8M | ---- | 18.31%67.2M | ---- | -81.93%56.8M | ---- | 162.51%314.3M | ---- | -2,375.11%-502.8M |
| Cash from business operations | ---- | -23.11%1.4B | ---- | 96.24%1.82B | ---- | -59.15%928.7M | ---- | 125.41%2.27B | ---- | -23.43%1.01B |
| Other taxs | -466.61%-310.5M | 968.38%203.2M | -53.93%-54.8M | 65.59%-23.4M | 83.21%-35.6M | -114.76%-68M | -6,525.00%-212M | 426.03%460.8M | -108.06%-3.2M | 150.84%87.6M |
| Special items of business | 162.32%1.5B | -85.63%7.3M | 23.61%570.1M | 277.62%50.8M | 32.99%461.2M | 84.37%-28.6M | -73.55%346.8M | -169.87%-183M | 301.13%1.31B | --261.9M |
| Net cash from operations | 129.96%1.19B | -12.87%1.61B | 21.08%515.3M | 122.32%1.85B | 215.73%425.6M | -67.39%832.1M | -89.69%134.8M | 87.86%2.55B | 256.82%1.31B | 18.61%1.36B |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | 0.00%100K | -91.67%100K | --100K | --1.2M | ---- | ---- | ---- | -87.50%100K | ---- | -78.38%800K |
| Purchase of fixed assets | -0.83%-424.3M | -14.58%-905.2M | -39.29%-420.8M | -39.95%-790M | -48.02%-302.1M | 0.91%-564.5M | 25.48%-204.1M | -10.71%-569.7M | -7.62%-273.9M | -8.04%-514.6M |
| Purchase of intangible assets | ---- | -1,758.33%-22.3M | ---1.4M | 29.41%-1.2M | ---- | 58.54%-1.7M | 75.00%-1M | -105.00%-4.1M | -400.00%-4M | -1,900.00%-2M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --27.5M | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---2.04B | ---2.04B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 82.79%-424.2M | -275.97%-2.97B | -715.92%-2.46B | -46.65%-790M | -47.29%-302.1M | 6.10%-538.7M | 26.20%-205.1M | -11.23%-573.7M | -8.85%-277.9M | -7.28%-515.8M |
| Net cash before financing | 139.02%760.8M | -228.15%-1.36B | -1,678.62%-1.95B | 261.25%1.06B | 275.68%123.5M | -85.17%293.4M | -106.82%-70.3M | 134.78%1.98B | 825.61%1.03B | 26.81%842.4M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -47.39%1.64B | 89.94%5.32B | 290.40%3.12B | 300.00%2.8B | 220.00%800M | 159.26%700M | -7.41%250M | -77.03%270M | -51.27%270M | 422.53%1.18B |
| Refund | -64.72%-2.03B | -54.79%-5.43B | -94.27%-1.23B | -120.49%-3.51B | 23.96%-634.9M | -37.15%-1.59B | 3.59%-835M | 28.77%-1.16B | -37.26%-866.1M | -121.21%-1.63B |
| Issuing shares | -30.12%337.5M | 137,050.00%1.65B | 40,150.00%483M | 1,100.00%1.2M | 1,100.00%1.2M | -99.97%100K | -99.97%100K | 25,250.00%304.2M | 304,200.00%304.3M | 0.00%1.2M |
| Interest paid - financing | 66.60%-79.7M | -2.08%-387.2M | -56.87%-238.6M | -36.54%-379.3M | -81.29%-152.1M | 0.43%-277.8M | 15.59%-83.9M | 23.06%-279M | 35.33%-99.4M | 22.60%-362.6M |
| Dividends paid - financing | ---103.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---10.5M | ---- | ---- | ---- | ---- | ---- | ---3.1M | ---3.1M | ---- |
| Other items of the financing business | -36.49%4.7M | -94.55%7.6M | -77.58%7.4M | 486.13%139.5M | 1,131.25%33M | 275.00%23.8M | 56.76%-3.2M | 15.00%-13.6M | -4.23%-7.4M | 45.39%-16M |
| Net cash from financing operations | -111.59%-246.2M | 212.07%1.1B | 7,484.29%2.12B | 16.27%-985.1M | 104.07%28M | -28.55%-1.18B | -64.41%-687.9M | -5.54%-915.2M | -62.23%-418.4M | 17.31%-867.2M |
| Net Cash | 195.75%514.6M | -439.97%-254.3M | 14.85%174M | 108.47%74.8M | 119.98%151.5M | -183.11%-883.1M | -223.93%-758.2M | 4,384.68%1.06B | 517.33%611.8M | 93.55%-24.8M |
| Begining period cash | -56.89%192.7M | 20.10%447M | 20.10%447M | -70.35%372.2M | -70.35%372.2M | 551.43%1.26B | 551.43%1.26B | -11.40%192.7M | -11.40%192.7M | -63.86%217.5M |
| Cash at the end | 13.90%707.3M | -56.89%192.7M | 18.58%621M | 20.10%447M | 5.35%523.7M | -70.35%372.2M | -38.21%497.1M | 551.43%1.26B | 1,034.70%804.5M | -11.40%192.7M |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.